Does the media prefer AGL or HIMS?

In the previous week, Hims & Hers Health had 23 more articles in the media than Agilon Health. MarketBeat recorded 26 mentions for Hims & Hers Health and 3 mentions for Agilon Health. Hims & Hers Health's average media sentiment score of 0.22 beat Agilon Health's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 5 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 5 Negative mention(s) 3 Very Negative mention(s) Neutral

Does the media favor BLLN or AGL?

In the previous week, Billiontoone had 2 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for Billiontoone and 3 mentions for Agilon Health. Billiontoone's average media sentiment score of 0.41 beat Agilon Health's score of 0.00 indicating that Billiontoone is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer AGL or SHC?

In the previous week, Sotera Health had 7 more articles in the media than Agilon Health. MarketBeat recorded 10 mentions for Sotera Health and 3 mentions for Agilon Health. Sotera Health's average media sentiment score of 1.35 beat Agilon Health's score of 0.00 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sotera Health 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is AGL or RDNT more profitable?

RadNet has a net margin of -0.66% compared to Agilon Health's net margin of -6.09%. RadNet's return on equity of 2.77% beat Agilon Health's return on equity. Company Net Margins Return on Equity Return on Assets Agilon Health -6.09% -146.03% -24.55% RadNet -0.66% 2.77% 0.97%

Does the media prefer AGL or RDNT?

In the previous week, RadNet had 2 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for RadNet and 3 mentions for Agilon Health. RadNet's average media sentiment score of 0.42 beat Agilon Health's score of 0.00 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RadNet 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, AGL or VCYT?

Veracyte has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agilon Health $5.82B 0.28 -$391.35M -$21.56 N/A Veracyte $561.90M 6.47 $66.35M $1.41 32.32

Is AGL or VCYT more profitable?

Veracyte has a net margin of 20.37% compared to Agilon Health's net margin of -6.09%. Veracyte's return on equity of 9.26% beat Agilon Health's return on equity. Company Net Margins Return on Equity Return on Assets Agilon Health -6.09% -146.03% -24.55% Veracyte 20.37% 9.26% 8.61%

Does the media prefer AGL or VCYT?

In the previous week, Veracyte had 16 more articles in the media than Agilon Health. MarketBeat recorded 19 mentions for Veracyte and 3 mentions for Agilon Health. Veracyte's average media sentiment score of 0.63 beat Agilon Health's score of 0.00 indicating that Veracyte is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Veracyte 7 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Agilon Health (AGL) Competitors

$96.00 +4.39 (+4.79%)

As of 12:52 PM Eastern

Compare

AGL vs. HIMS, BLLN, SHC, RDNT, and VCYT

Should you buy Agilon Health stock or one of its competitors? MarketBeat compares Agilon Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Agilon Health include Hims & Hers Health (HIMS), Billiontoone (BLLN), Sotera Health (SHC), RadNet (RDNT), and Veracyte (VCYT).

How does Agilon Health compare to Hims & Hers Health?

Agilon Health (NYSE:AGL) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

In the previous week, Hims & Hers Health had 23 more articles in the media than Agilon Health. MarketBeat recorded 26 mentions for Hims & Hers Health and 3 mentions for Agilon Health. Hims & Hers Health's average media sentiment score of 0.22 beat Agilon Health's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	5 Negative mention(s)	3 Very Negative mention(s)	Neutral

Agilon Health presently has a consensus target price of $66.50, indicating a potential downside of 30.73%. Hims & Hers Health has a consensus target price of $31.43, indicating a potential upside of 3.18%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	3 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.14
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

Hims & Hers Health has a net margin of -0.56% compared to Agilon Health's net margin of -6.09%. Hims & Hers Health's return on equity of 6.10% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Hims & Hers Health	-0.56%	6.10%	1.52%

63.5% of Hims & Hers Health shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Hims & Hers Health has lower revenue, but higher earnings than Agilon Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.82B	0.28	-$391.35M	-$21.56	N/A
Hims & Hers Health	$2.37B	2.98	$128.37M	-$0.09	N/A

Agilon Health has a beta of 2.98, suggesting that its stock price is 198% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market.

Summary

Hims & Hers Health beats Agilon Health on 12 of the 16 factors compared between the two stocks.

How does Agilon Health compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

Billiontoone presently has a consensus price target of $126.00, indicating a potential downside of 8.58%. Agilon Health has a consensus price target of $66.50, indicating a potential downside of 30.73%. Given Billiontoone's stronger consensus rating and higher possible upside, research analysts plainly believe Billiontoone is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Agilon Health	3 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.14

In the previous week, Billiontoone had 2 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for Billiontoone and 3 mentions for Agilon Health. Billiontoone's average media sentiment score of 0.41 beat Agilon Health's score of 0.00 indicating that Billiontoone is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Billiontoone has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Billiontoone's return on equity of 0.00% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Agilon Health	-6.09%	-146.03%	-24.55%

Billiontoone has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	20.77	$7.45M	$0.55	250.58
Agilon Health	$5.82B	0.28	-$391.35M	-$21.56	N/A

Summary

Billiontoone beats Agilon Health on 12 of the 13 factors compared between the two stocks.

How does Agilon Health compare to Sotera Health?

Agilon Health (NYSE:AGL) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

In the previous week, Sotera Health had 7 more articles in the media than Agilon Health. MarketBeat recorded 10 mentions for Sotera Health and 3 mentions for Agilon Health. Sotera Health's average media sentiment score of 1.35 beat Agilon Health's score of 0.00 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sotera Health	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilon Health has a beta of 2.98, meaning that its stock price is 198% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.76, meaning that its stock price is 76% more volatile than the broader market.

Sotera Health has a net margin of 9.91% compared to Agilon Health's net margin of -6.09%. Sotera Health's return on equity of 39.73% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Sotera Health	9.91%	39.73%	7.05%

Agilon Health presently has a consensus target price of $66.50, indicating a potential downside of 30.73%. Sotera Health has a consensus target price of $20.25, indicating a potential upside of 12.26%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts clearly believe Sotera Health is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	3 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.14
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Sotera Health has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.82B	0.28	-$391.35M	-$21.56	N/A
Sotera Health	$1.19B	4.33	$77.94M	$0.41	44.00

91.0% of Sotera Health shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Sotera Health beats Agilon Health on 14 of the 16 factors compared between the two stocks.

How does Agilon Health compare to RadNet?

Agilon Health (NYSE:AGL) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

RadNet has a net margin of -0.66% compared to Agilon Health's net margin of -6.09%. RadNet's return on equity of 2.77% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
RadNet	-0.66%	2.77%	0.97%

RadNet has lower revenue, but higher earnings than Agilon Health. RadNet is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.82B	0.28	-$391.35M	-$21.56	N/A
RadNet	$2.04B	2.58	-$18.65M	-$0.18	N/A

77.9% of RadNet shares are held by institutional investors. 2.5% of Agilon Health shares are held by company insiders. Comparatively, 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Agilon Health has a beta of 2.98, indicating that its share price is 198% more volatile than the broader market. Comparatively, RadNet has a beta of 1.36, indicating that its share price is 36% more volatile than the broader market.

Agilon Health presently has a consensus price target of $66.50, indicating a potential downside of 30.73%. RadNet has a consensus price target of $87.43, indicating a potential upside of 30.44%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	3 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.14
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80

In the previous week, RadNet had 2 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for RadNet and 3 mentions for Agilon Health. RadNet's average media sentiment score of 0.42 beat Agilon Health's score of 0.00 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

RadNet beats Agilon Health on 14 of the 17 factors compared between the two stocks.

How does Agilon Health compare to Veracyte?

Agilon Health (NYSE:AGL) and Veracyte (NASDAQ:VCYT) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Agilon Health has a beta of 2.98, meaning that its stock price is 198% more volatile than the broader market. Comparatively, Veracyte has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

Veracyte has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.82B	0.28	-$391.35M	-$21.56	N/A
Veracyte	$561.90M	6.47	$66.35M	$1.41	32.32

In the previous week, Veracyte had 16 more articles in the media than Agilon Health. MarketBeat recorded 19 mentions for Veracyte and 3 mentions for Agilon Health. Veracyte's average media sentiment score of 0.63 beat Agilon Health's score of 0.00 indicating that Veracyte is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Veracyte	7 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Veracyte has a net margin of 20.37% compared to Agilon Health's net margin of -6.09%. Veracyte's return on equity of 9.26% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Veracyte	20.37%	9.26%	8.61%

Agilon Health presently has a consensus price target of $66.50, indicating a potential downside of 30.73%. Veracyte has a consensus price target of $56.13, indicating a potential upside of 23.18%. Given Veracyte's stronger consensus rating and higher probable upside, analysts clearly believe Veracyte is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	3 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.14
Veracyte	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.60

Summary

Veracyte beats Agilon Health on 12 of the 14 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AGL vs. The Competition

Export

Metric	Agilon Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.60B	$9.94B	$6.80B	$23.74B
Dividend Yield	N/A	2.52%	2.59%	4.21%
P/E Ratio	-4.45	25.62	282.16	31.39
Price / Sales	0.28	5.50	576.18	165.39
Price / Cash	N/A	26.24	28.60	18.73
Price / Book	12.57	5.22	10.96	4.81
Net Income	-$391.35M	$311.05M	$3.49B	$1.07B
7 Day Performance	-1.73%	0.10%	0.45%	0.71%
1 Month Performance	-12.95%	-0.58%	-4.26%	0.47%
1 Year Performance	126.55%	27.65%	63.09%	20.41%

Agilon Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AGL Agilon Health	0.7377 of 5 stars	$96.00 +4.8%	$66.50 -30.7%	+114.8%	$1.60B	$5.82B	N/A	1,076	Upcoming Earnings
HIMS Hims & Hers Health	2.4877 of 5 stars	$30.23 +7.6%	$31.43 +4.0%	-55.6%	$6.50B	$2.35B	N/A	2,442	Upcoming Earnings Gap Up
BLLN Billiontoone	2.6308 of 5 stars	$127.98 +1.5%	$126.00 -1.5%	N/A	$5.80B	$305.11M	232.69	620
SHC Sotera Health	3.4653 of 5 stars	$17.24 -0.6%	$20.25 +17.5%	+60.2%	$4.95B	$1.16B	42.05	3,000	Positive News Upcoming Earnings
RDNT RadNet	3.381 of 5 stars	$61.51 -0.1%	$87.43 +42.1%	+16.6%	$4.84B	$2.04B	N/A	11,264	Positive News Upcoming Earnings Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AGL) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilon Health (AGL) Competitors

AGL vs. HIMS, BLLN, SHC, RDNT, and VCYT

How does Agilon Health compare to Hims & Hers Health?

Summary

How does Agilon Health compare to Billiontoone?

Summary

How does Agilon Health compare to Sotera Health?

Summary

How does Agilon Health compare to RadNet?

Summary

How does Agilon Health compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilon Health (AGL) Competitors

AGL vs. HIMS, BLLN, SHC, RDNT, and VCYT

How does Agilon Health compare to Hims & Hers Health?

Does the media prefer AGL or HIMS?

Do analysts recommend AGL or HIMS?

Is AGL or HIMS more profitable?

Do institutionals & insiders have more ownership in AGL or HIMS?

Which has stronger valuation & earnings, AGL or HIMS?

Which has more risk and volatility, AGL or HIMS?

Summary

How does Agilon Health compare to Billiontoone?

Do analysts recommend BLLN or AGL?

Does the media favor BLLN or AGL?

Is BLLN or AGL more profitable?

Which has preferable earnings and valuation, BLLN or AGL?

Summary

How does Agilon Health compare to Sotera Health?

Does the media prefer AGL or SHC?

Which has more volatility and risk, AGL or SHC?

Is AGL or SHC more profitable?

Do analysts prefer AGL or SHC?

Which has better valuation & earnings, AGL or SHC?

Do insiders and institutionals have more ownership in AGL or SHC?

Summary

How does Agilon Health compare to RadNet?

Is AGL or RDNT more profitable?

Which has better earnings & valuation, AGL or RDNT?

Do insiders & institutionals believe in AGL or RDNT?

Which has more volatility and risk, AGL or RDNT?

Do analysts recommend AGL or RDNT?

Does the media prefer AGL or RDNT?

Summary

How does Agilon Health compare to Veracyte?

Which has more volatility and risk, AGL or VCYT?

Which has preferable valuation & earnings, AGL or VCYT?

Does the media prefer AGL or VCYT?

Is AGL or VCYT more profitable?

Do analysts recommend AGL or VCYT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools